Fig. 1From: Detection and therapy of neuroblastoma minimal residual disease using [64/67Cu]Cu-SARTATE in a preclinical model of hepatic metastasesChemical structures. The chemical structures of MeCOSar (top) and Cu-SARTATE (bottom) are shownBack to article page